Fact CheckerSign in

NCT07746102Recruiting

Assessment of the Impact of Repeated Ischemic Preconditioning Episodes on Hemodynamic and Metabolic Parameters in Patients at Various Stages of Chronic Kidney Disease

Source: ClinicalTrials.gov · Last updated 4 Aug 2026

Brief summary (registry, in English)

The aim of our study is to evaluate the impact of repeated episodes of ischemic quenching on changes in blood pressure, heart rate and laboratory parameters of inflammation in patients with kidney diseases. There is credible evidence that intentionally producing periods of ischemia provides protection of the myocardium and blood vessels against subsequent ischemic injury. The examination will be performed during hospitalization in the Department of Nephrology, Hypertension, Transplantology and Internal Diseases and will last 4 days. On the first day, blood pressure will be measured using an automatic blood pressure monitor, radial artery pulse, blood saturation will be measured using a pulse oximeter, and approximately 6 ml of venous blood will be collected from the elbow bend area for laboratory tests. Then, compression of the lower limb below the knee will be performed using a blood pressure cuff. Four 5-minute cycles of inflation and deflation of the cuff will be performed. The pressure on the lower limb will be repeated on the next two days. On the last day of the examination, blood pressure, heart rate and blood saturation will be measured again, and approximately 6 ml of venous blood will be collected again for laboratory tests.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
60 (estimated)
First submitted
8 May 2026
Start date
23 Jul 2026
Primary completion date
1 Sept 2026
Lead sponsor
Medical University of Lodz
NCT number
NCT07746102

What you commit to

  • Study type: Interventional
  • Planned participants: 60
  • From 23 Jul 2026 to the primary completion date, 1 Sept 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • \-

Who the study is looking for

  • obtaining the patient's voluntary, informed consent to participate in the experiment,
  • chronic kidney disease in stages G1-G5,
  • women and men over 18 years of age.
  • failure to meet the qualification criteria for participation in the study,
  • consciousness disorders,
  • heart failure (NYHA IV),
  • severe anemia (Hb concentration\<8g/dL),
  • features of muscle cell damage (e.g. rhabdomyolysis),
  • peripheral circulation disorders, peripheral vascular diseases.

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Medical University of Lodzi
Coordinator of this site? Confirm its status
LodzPolandRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.